The UK Vaccine Minister Nadhim Zahawi has said he received a recommendations from the Joint Committee on Vaccination and Immunisation (JCVI) about whether to recommend vaccines for under-18s, BBC News reported on Monday.
Zahawi told BBC Breakfast he will make a statement to Parliament later, but he says the JCVI has recommended that children with medical conditions that make them vulnerable to COVID-19 should be vaccinated, along with those who live with clinically vulnerable people.
He also said the committee recommends that children close to their 18th birthday should have the vaccine.
However, the JCVI will be keeping under review whether or not to vaccinate healthy children aged 12 to 17.
Reportedly, the committee is concerned about some data suggesting there may be rare cases of myocarditis, an inflammation of the heart muscle, linked to the vaccine.
Sen-Jam Pharmaceutical and KVK Tech complete final development deliverables for SJP-002C
OSE Immunotherapeutics forms strategic alliance with Inserm Transfert and Nantes University
ResVita Bio completes face-to-face Pre-IND meeting with FDA for RVB-003
N4 Pharma advances RNA delivery breakthrough with SRI collaboration
EMA recommends marketing approval of Alvotech's Gobivaz biosimilar to Simponi
Evommune reveals further positive data from Phase 2 EVO756 trial
J & D Pharmaceuticals receives Orphan Drug Designation for JD-004
Ascletis presents Phase III results of denifanstat (ASC40) for acne treatment at EADV Congress 2025
Sanofi reports positive phase 2a results for brivekimig in hidradenitis suppurativa
Kodiak reports positive APEX data for KSI-101 in macular edema secondary to inflammation
Onco3R Therapeutics receives Belgian regulatory approval for clinical trial of novel SIK3 inhibitor
Mesoblast agrees option to issue USD50m of convertible notes
LPOXY agrees financing to fund registrational STOP-Cdiff trial